The c-Myb oncoprotein is a DNA-binding transcription factor with a key role in early stages of hematopoiesis. To expand our knowledge of partners cooperating with c-Myb, we performed a yeast two-hybrid screening with full-length c-Myb as bait. Here, we report FLICEassociated huge protein (FLASH)/CASP8AP2 as a novel Myb-interacting protein. We show that FLASH interacts with the DNA-binding domain of c-Myb and enhances c-Myb-dependent reporter activity and expression of endogenous c-Myb target genes. Chromatin immunoprecipitation assays revealed that FLASH and c-Myb both associate with the MYC promoter region as well as with the intronic enhancer of the c-Myb target gene ADA. Furthermore, siRNA knock-down of FLASH or c-Myb both result in a reduction of MYC and ADA expression. The co-activator effect is mediated through the C-terminal part of FLASH, which binds c-Myb. The FLASH-induced enhancement is comparable with the increase seen with the c-Myb co-activator p300. We find FLASH localized in discrete nuclear speckles in several cell lines, co-localized with c-Myb in active RNA polymerase II foci. These results imply a novel molecular mechanism of regulation of c-Myb activity. We propose that c-Myb cooperates with FLASH in foci associated with active RNA polymerase II, leading to enhancement of Myb-dependent gene activation.
Introduction
The c-myb gene encodes a transcription factor required for proliferation, differentiation and survival of normal and leukemic hematopoietic cells (Oh and Reddy, 1999) . Mice with a non-functional c-myb gene suffer from severe anaemia and die by embryonic day 15 (Mucenski et al., 1991) . More recent studies have uncovered that distinct threshold levels of c-Myb are required at different stages of hematopoiesis (Emambokus et al., 2003; Sakamoto et al., 2006; Vegiopoulos et al., 2006) . Two independent genetic screenings in mice have identified three point mutations in c-myb affecting specific stages of hematopoiesis causing a range of hematopoietic defects (Carpinelli et al., 2004; Sandberg et al., 2005) . One mechanism involved appeared to be impaired co-activator interaction. These and other observations underline the importance of co-regulator interactions for understanding c-Myb function. Given the unexpected complexity of the co-regulator level in other transcription systems, we believe that there is still a need for identifying additional Myb-interaction partners to understand how c-Myb transcriptional activity is regulated, and how oncogenic activation may affect regulatory mechanisms.
In this paper, we describe a novel co-regulator of c-Myb, namely FLICE-associated huge (FLASH) protein or CASP8AP2. FLASH was first identified as a component of the Fas-caspase-8 apoptotic pathway (Imai et al., 1999) . The involvement of FLASH in Fas-induced apoptosis appears to be through a previously unrecognized nuclear pathway (Milovic-Holm et al., 2007) . However, FLASH appears to have a broader nuclear function since it acts both as enhancer and repressor of steroid hormone receptor-mediated transactivation (Kino and Chrousos, 2003; Kino et al., 2004; Obradovic et al., 2004) . Although the precise molecular function of FLASH still remains to be defined, one report identified FLASH as a gene product essential for cell division, based on the observation that FLASH mRNA knockdown caused the cells to die upon entry into mitosis (Kittler et al., 2004) . FLASH was also found to be a promising prognostic marker in acute lymphoblastic leukemia (Flotho et al., 2006) . Recently, interesting data were put forward in favour of FLASH being a component of Cajal bodies with a specific functional role in histone transcription and S-phase progression (Barcaroli et al., 2006a, b) .
We find FLASH to be mainly nuclear and localized to nuclear bodies in several cell lines, structures in which we also find c-Myb co-localized with FLASH. Triple immunostaining with active RNA polymerase II revealed that the Myb-FLASH interaction is associated with active transcription foci. Functional analysis shows that FLASH enhances c-Myb-dependent reporter activation, and knock-down and ChIP studies support their cooperation in hematopoietic cells. These results imply a role for FLASH as a cooperating partner of c-Myb.
Results

c-Myb-FLASH interaction identified by yeast two-hybrid screening
To identify novel proteins that interact with the human c-Myb protein, we performed a yeast two-hybrid screening with full-length c-Myb as bait (Dahle et al., 2003) . Among the positive interacting clones, we identified a sequence encoding the C-terminal part of human FLASH (or CASP8AP2; NM_012115). The interaction between c-Myb and FLASH was verified in yeast by retransformation and growth on reporterselective media (Figure 1) , by an X-gal overlay assay ( Figure 1 ) and by liquid b-galactosidase assay (data not shown).
FLASH interacts with the DNA-binding domain of c-Myb
To confirm the interaction by independent methods, we performed GST pulldown assays using the region of FLASH isolated in the Y2H screen (GST-FLASH-D3). The purified fusion protein was incubated with lysate from COS-1 cells transiently transfected with an expression plasmid for human c-Myb. c-Myb was retained on GST-FLASH-D3 but not on the GST control ( Figure 2b ).
An even stronger interaction was detected between GST-FLASH-D3 and a truncated form of c-Myb (amino acids 1-443). This indicates that the interaction may be negatively influenced by the C-terminal region of c-Myb. The oncogenic version AMV v-Myb harbours the same C-terminal truncation as c-Myb , and has in addition an N-terminal truncation and ten pointmutations compared to wildtype c-Myb (Lipsick and Wang, 1999) . GST-FLASH-D3 bound AMV v-Myb as efficiently as the truncated c-Myb and clearly stronger than full-length c-Myb (Figure 2b ). Thus, it appears that neither the point mutations nor the N-terminal deletion in v-Myb had any major effect on its affinity for FLASH. The reason why the C-terminal truncations in c-Myb appear to enhance binding to FLASH was not further investigated.
To map in more detail the interacting region in c-Myb, reverse GST pulldown assays were carried out using different domains of c-Myb expressed as GST-fusions (Figure 2a ). When labelled FLASH-D2 was incubated with eight different GST-Myb proteins, the FLASH-protein was significantly retained only on the DNA-binding domain fused to GST (GST-DBD) (Figure 2c upper panel) . When full-length FLASH was analysed in this system, we observed the same preference for the DBD as observed with the C-terminal region of FLASH (Figure 2c lower panel) .
A third line of evidence for the interaction was provided by co-immunoprecipitation assays first using lysates from COS-1 cells transfected with Myc-FLASH-D1 and c-Myb. As shown in Figure 2d , c-Myb was coimmunoprecipitated with Myc-FLASH-D1 (anti-Myc antibody), but not with anti-HA control antibody. Furthermore, co-immunoprecipitation in lysates from human erythroleukemia K562 cells showed that FLASH and c-Myb also interact at the endogenous level. After immunoprecipitation with anti-c-Myb, endogeneous FLASH was detected in the precipitate (Figure 2e ). Taken together, four independent interaction assays supported the validity of an interaction between c-Myb and FLASH both in vitro and in vivo involving the DNA-binding domain of c-Myb and the C-terminal part of FLASH.
FLASH is localized in nuclear speckles in several cell lines As it has been unclear whether FLASH operates in the cytoplasm or in the nucleus (see Discussion section), we next examined its subcellular localization. An HAtagged FLASH construct was expressed in CV-1 cells, and the protein was detected by immunofluorescence with anti-HA and anti-FLASH antibodies. We found FLASH to be localized in well-defined nuclear speckles (Figure 3a) .
We examined the endogenous distribution of FLASH in NIH3T3 and Myb-positive K562, Molt4 and Jurkat cells using an anti-FLASH antibody (Figure 3b ). FLASH localized in speckles in the nucleus in all cell types. This nuclear distribution was confirmed by western analysis of nuclear and cytoplasmic extracts of K562 cells, and of CV-1 cells transfected with HA-FLASH (Figure 3c ), as well as in NIH3T3 and Jurkat cells (data not shown). FLASH was exclusively detected in the nuclear fraction. Hence, we conclude that FLASH is predominantly localized in nuclear speckles. FLASH: co-activator of c-Myb AH Alm-Kristiansen et al c-Myb and FLASH co-localizes in nuclear speckles We next analysed whether c-Myb is localized in the same structures as FLASH. HA-tagged FLASH and FLAGtagged c-Myb were co-expressed in CV-1 and HeLa cells, and in both cases the two proteins were found to be co-localized in nuclear speckles (Figures 4a and b) . When these cells are transfected with c-Myb only, generally about 50% of the transfected cells show staining of c-Myb in punctual structures. We noticed that upon co-transfection with FLASH, c-Myb was consistently observed in punctual structures in a significant higher fraction, close to 100% of the c-Myb positive cells (n ¼ 100), being consistent with the two proteins having affinity for each other.
To analyse whether FLASH and c-Myb are found colocalized endogenously in hematopoietic cells, we performed immunofluorescence and confocal microscopy in K562 cells. We found endogenous c-Myb both as diffuse and punctuate forms in the nucleus. A fraction of these c-Myb speckles co-localized with endogenous FLASH (Figure 4c ). This suggests that not all c-Myb and FLASH foci are in constant association, but that either a fraction of the foci associates or that the foci at some time points come together in hematopoietic cells. The most likely explanation is that the interaction is dynamic in nature.
FLASH is partly co-localized with PML nuclear bodies and Cajal bodies Many nuclear proteins are localized in various nuclear bodies (Zimber et al., 2004) . We reasoned that knowing the nature of the nuclear bodies in which FLASH is found, might shed light on its function. As the size and morphology of the 'FLASH-bodies' are reminiscent of RNA splicing bodies (Spector et al., 1991) and promyelocytic leukaemia (PML) nuclear bodies (Salomoni and Pandolfi, 2002), we examined a possible co-localization with these structures. As seen in Figure 5a , the FLASH and spliceosome nuclear foci are clearly not co-localized. We have earlier reported that c-Myb co-localizes with PML nuclear bodies (Dahle et al., 2004) . We therefore addressed the association between FLASH and PML. Interestingly, the nuclear structures formed by FLASH and PML seem to only partly overlap (Figure 5b ). We observed a 
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AH Alm-Kristiansen et al high frequency of juxtaposed staining of the two, but not full overlap. The same was observed in HeLa cells (data not shown). These observations suggest that a subset of FLASH is localized in the vicinity of PML nuclear bodies, most probably as the result of a dynamic interaction. As PML nuclear bodies are reported to be partially associated with Cajal bodies (Sun et al., 2005) , we next tested whether FLASH co-localized with coilin, a marker of Cajal bodies. Again we observed that the staining varied from none to nearly complete colocalization ( Figure 5c ). The same was observed in HeLa cells (data not shown). Thus, FLASH proteins appear to form distinct 'FLASH bodies' located in close association with both PML nuclear bodies and Cajal bodies.
FLASH enhances c-Myb-dependent reporter activation
Having found that FLASH interacts with c-Myb, a key question was the functional consequences of this association. The influence of FLASH on c-Myb- Figure 3 FLICE-associated huge protein (FLASH) is localized in nuclear speckles in several cell lines. (a) CV-1 cells were transfected with pHA-FLASH, and inspected by indirect immunofluorescence and confocal microscopy. FLASH was detected using a mouse anti-HA antibody for the N-terminal HA-tag followed by Alexa Fluor 594 goat anti-mouse IgG (red signal), and a rabbit anti-FLASH antibody for the C-terminal part of FLASH and Alexa Fluor 488 goat anti-rabbit IgG (green signal). Co-localization is visualized as yellow colour when merging the images (right panel). (b) Endogenous distribution of FLASH in NIH3T3 and Myb-positive Jurkat, K562 and Molt4 cells were detected using anti-FLASH antibody as described in Materials and methods. DNA was labelled by Hoechst 33258. (c) Nuclear and cytoplasmic extracts from K562 cells (endogenous) and CV-1 cells transfected with pHA-FLASH and pCIneo empty vector as indicated in the figure, were analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. FLASH was detected with rabbit anti-FLASH antibody. Anti-lamin B and anti-actin antibodies were used as nuclear and cytoplasmic markers, respectively.
FLASH: co-activator of c-Myb AH Alm-Kristiansen et al dependent transactivation was evaluated using effectorreporter assays first with a synthetic Myb-responsive reporter plasmid harboring four Myb-recognition elements (pTA-4xMRE-SEAP). Increasing amounts of FLASH led to increased Myb activity (Figure 6a ). The same was observed with mouse FLASH. Human and mouse FLASH proteins are only 66% identical (BlastP), but their ability to bind and activate c-Myb appears to be well conserved.
A very similar activation profile was observed using reporters driven by established Myb-responsive promoters (Figures 6b and c) , both the murine RAG-2 promoter (Wang et al., 2000; Miranda et al., 2002) and the MYC promoter (Schmidt et al., 2000) . Here the FLASH-induced enhancement was three to fourfold the level measured with c-Myb alone. Transfection of FLASH alone had only marginal stimulatory effects. Since the truncated c-Myb[1-443] and v-Myb, the leukemogenic cousin of c-Myb, both were demonstrated to interact efficiently with FLASH (Figure 2b) , their coactivation by FLASH were investigated. Both of these Myb-proteins are intrinsically more active than fulllength c-Myb due to lack of the negative regulatory domain. Still, co-transfection with FLASH increased their transcriptional activity, about fourfold the activity of c-Myb and v-Myb alone (Figure 6d ).
The co-activator ability of FLASH resembles p300 p300 is well established as a co-activator of c-Myb (Dai et al., 1996; Oelgeschlager et al., 1996; Kasper et al., 2002; Sandberg et al., 2005) . To directly compare the coactivation potency of FLASH and p300, they were both included in reporter gene assays. As seen from Figure 7 , FLASH and p300 alone had hardly any effect, but upon co-transfection the activity increased about threefold. From this we conclude that FLASH and p300 seem to be equally effective as co-activators in this system.
FLASH activates the expression of endogenous c-Myb target genes in hematopoietic cells
Having found that FLASH enhances Myb-specific activity on transiently transfected reporters, we tested whether the same is true for endogenous target genes. First, we tested the co-activator function using an established model system for activation of a chromatinembedded Myb target gene, mim-1 (Burk et al., 1993; Ness et al., 1993) . Activation of the mim-1 gene was monitored by real-time PCR. As shown in Figure 8a , cotransfection of c-Myb with increasing amounts of FLASH resulted in an enhanced activation in a dosedependent manner, confirming the role of FLASH as a co-activator of c-Myb on chromatin embedded target genes.
Then we specifically knocked down FLASH in the cMyb expressing human erythroleukemia K562 cells, and monitored the expression of a set of established c-Myb target genes. The cells were nucleofected with siRNA directed against FLASH, or a control siRNA and then allowed to grow for 24 h. While the mRNA of FLASH dropped to only B40% of its normal level (Figure 8c ), the specific siRNA caused a clear knockdown of FLASH proteins as revealed by western (Figure 8b ). There was no effect of the control siRNA (Figure 8b ), nor any change in c-Myb protein level (Figure 8b) . To monitor the effect of reduced FLASH levels on expression of c-Myb target genes, we focused on two previously reported targets: MYC and adenosine deaminase (ADA) (Ess et al., 1995; Schmidt et al., 2000) , which we have verified to be responsive to c-Myb FLASH: co-activator of c-Myb AH Alm-Kristiansen et al knockdown in K562 cells . The mRNA expression of MYC and ADA were both significantly downregulated as a consequence of FLASH knockdown (Figure 8c ). Taken together, these observations support our hypothesis that FLASH cooperates with c-Myb in a positive fashion to activate the transcription of at least a subset of endogenous c-Myb target genes. Finally, using a chromatin immunoprecipitation (ChIP) approach we addressed whether c-Myb and FLASH occupied the same regulatory regions in c-Myb responsive genes in hematopoietic cells. As shown in Figure 8d , we found that c-Myb and FLASH bound to the promoter region of the MYC gene harbouring a strong c-Myb-responsive element (Schmidt et al., 2000) as well as to the c-Myb responsive intronic enhancer of the ADA gene (Ess et al., 1995) . As a positive reference for FLASH ChIP we used binding to the histone H3 promoter previously reported to be occupied by and regulated by FLASH (Barcaroli et al., 2006a) . The enrichment of FLASH measured on MYC and ADA were very close to what we observed on the histone H3 promoter (Figure 8d) . We conclude that c-Myb and FLASH both are found associated with promoters and regulatory elements of genes that respond to knockdown of either of the factors, strongly supporting their joint action in the process of gene activation.
FLASH contains a functional activation domain
The mechanism by which FLASH causes enhanced c-Myb activity remains to be determined. An obvious possibility is that c-Myb recruits FLASH to specific promoters allowing FLASH to exert its function there. Such a mechanism implies that FLASH should cause activation also when artificially recruited to a Mybindependent promoter in a Gal4-tethering assay. As predicted, when fused to the Gal4p DNA-binding domain, FLASH activated transcription from the reporter in a dose-dependent manner ( Figure 9 ) and showed an approximately fivefold induction compared with the Gal4p-DBD alone. Non-fused FLASH had no influence on the activity (data not shown). When the C-terminal of FLASH was deleted (FLASH-DD1), the activation effect was significantly reduced, suggesting that FLASH contains an inherent transactivation c-Myb and FLASH are co-localized with active RNA polymerase II Having established co-activation and co-localization, we next asked whether transcription actually occurs in the FLASH containing foci. To test this, we performed confocal imaging of active RNA polymerase II using a mouse monoclonal antibody against RNA polymerase II phosphorylated on Ser-5 in the carboxy-terminal domain (CTD). The CTD of RNA polymerase II becomes highly phosphorylated during transcription, mainly on Ser-5 during initiation, before switching to Ser-2 during elongation (Komarnitsky et al., 2000) . As shown in Figure 10a , endogenous FLASH associates with active RNA polymerase II, implying that transcription does take place in FLASH-positive bodies. The co-localization was even more evident when cells were transfected with FLASH (bottom Figure 10a) . Of 50 cells examined, 98% showed an association between FLASH foci and RNA polymerase II foci. Counting only FLASH-positive foci, 75% of these were co-localized with active RNA polymerase II. Furthermore, three-colour labelling showed that c-Myb colocalizes with FLASH and active RNA polymerase II (Figure 10b ). We conclude that FLASH is tightly associated with active RNA polymerase II foci, leading to enhancement of Myb-dependent gene activation. 
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Discussion
In many transcription systems the co-activator level has turned out to be considerably more complex than initially envisioned. To fully understand the mechanism of action of any given transcription factor, knowledge of its co-regulators is essential. For the transcription factor c-Myb, only a limited number of co-regulators have been reported, CBP/p300 being the primary co-activator studied (Dai et al., 1996; Oelgeschlager et al., 1996; Kasper et al., 2002; Sandberg et al., 2005) . Recently, we reported that Mi-2a also acts as a co-activator for c-Myb . In this study we have identified FLASH as another interaction partner of c-Myb having co-activating effects on c-Myb. Using full-length c-Myb as bait in a yeast two-hybrid screening, we identified FLASH as a novel Myb-binding protein.
The interaction was first verified in yeast (Figure 1 ). Physical interaction between c-Myb and FLASH was then demonstrated by co-immunoprecipitation and by GST-pulldown assays (Figure 2 ). The latter also allowed mapping of the interaction, which involves the C-terminal part of FLASH and the DNAbinding domain of c-Myb (Figure 2 ). Functional assays uncovered that FLASH acts as a co-activator of c-Myb function, both of transfected reporter genes and of a resident chromosomal target gene. FLASH knockdown caused downregulation of two c-Myb target genes, both of which were shown to bind FLASH and c-Myb in ChIP assays (Figures 6-8) . Finally, imaging studies revealed a high frequency of co-localization between FLASH and active RNA polymerase II foci (Figure 10 ), consistent with a role of FLASH as co-activator. While c-Myb is a nuclear factor, FLASH was originally described as being cytoplasmic, suggesting their interaction to be of no biological relevance. FLASH was discovered when cloned from a two-hybrid screening using the cytoplasmic procaspase-8 as bait. Consistently, the FLASH protein was described as mainly located in the cytoplasm (Imai et al., 1999) . Supporting this, Kino and co-workers found endogenous FLASH to be predominantly located in the cytoplasm and to shuttle to the nucleus upon TNFastimulation (Kino and Chrousos, 2003) . Based on this, we found it necessary to readdress the question of subcellular localization of FLASH before studying its effect on c-Myb function. In all our experiments, we found FLASH to be localized in discrete foci in the nucleus, with only a weak diffuse distribution in the nucleoplasm and cytoplasm. Since the same nuclear foci were seen with the use of antibodies against the N-and C-terminal parts of FLASH, the entire protein is found in the nucleus. Our data cannot be an overexpression artefact because we show that endogenously expressed FLASH is located in nuclear bodies in several cell lines (Figure 3b) . Finally, immunoblotting of nuclear and cytoplasmic extracts showed full-length FLASH primarily in the nuclear fraction (Figure 3c ). We therefore conclude that FLASH is predominantly nuclear, both when transfected into cells and when endogenously expressed. Very recently Barcaroli et al. (2006b) and Milovic-Holm et al. (2007) published evidence supporting the same conclusion.
We proceeded to examine whether FLASH and c-Myb indeed were co-localized in nuclear foci. As expected for interacting proteins, FLASH and c-Myb are found co-localized with very high frequency when overexpressed (Figures 4a and b) . We also showed that FLASH and c-Myb can be co-localized at endogenous levels in hematopoietic cells (Figure 4c ). The 'FLASH bodies' seem to be partly associated both with PML nuclear bodies and Cajal bodies. The number of FLASH foci that co-localized with PML nuclear bodies or Cajal bodies varied from cell to cell, from a high frequency of overlap to none. This might indicate that the association between FLASH and other nuclear bodies either depends on some kind of signals or differs during the cell cycle. More likely, a partial co-localization simply reflects a dynamic association. Strong evidence for association between FLASH and Cajal bodies was recently reported by Barcaroli et al., (2006b) . Association with PML nuclear bodies was also recently reported (Milovic-Holm et al., 2007) . The latter authors proposed that FLASH is a dynamic component of this nuclear compartment. We noticed in our experiments that FLASH was often observed adjacent to PML nuclear bodies, which is interesting because the periphery of PML nuclear bodies appear to be associated with newly synthesized RNA (Boisvert et al., 2000) . The results are presented as mean relative luciferase units (RLU)±s.e.m. To monitor the c-Myb levels, the cell lysates were immunoblotted using the c-Myb-specific antibody 5e11.
FLASH: co-activator of c-Myb AH Alm-Kristiansen et al Both Cajal bodies and PML nuclear bodies have important functions that are still not fully elucidated (Salomoni and Pandolfi, 2002; Dellaire and BazettJones, 2004; Cioce and Lamond, 2005; Handwerger and Gall, 2006) . One common concept in the models discussed, is that the bodies act as assembly sites or storage deposits, rather than as active sites of transcription. To examine whether transcription occurs in 'FLASH bodies', we studied the association of FLASH with phosphorylated, active RNA polymerase II. Interestingly we found FLASH co-localized with the polymerase. The triple immunostaining of c-Myb, FLASH FLASH: co-activator of c-Myb AH Alm-Kristiansen et al and Ser-5 phosphorylated RNA polymerase II indicates that transcription does occur in FLASH foci and suggests that FLASH may directly operate together with c-Myb and the polymerase in the transcriptional activation process. Having provided evidence for FLASH being a c-Mybinteracting protein found in active RNA polymerase II foci, a key question is the functional role of this interaction. Reporter gene assays revealed that FLASH specifically enhanced transcription driven by c-Myb in a dose-dependent manner (Figure 6 ). These experiments were extended to a resident chromatin-embedded Myb target gene, mim-1 in HD-11 cells, where we demonstrated that FLASH acts as a co-activator for c-Myb under more physiological conditions (Figure 8a) . Importantly, we found that endogenous FLASH binds to c-Myb target genes in the hematopoietic cell line K562. Specifically, c-Myb and FLASH both associate with the enhancer region of ADA and with the upstream region of MYC (Figure 8d ). Moreover, knock-down of FLASH in K562 cells results in reduced expression of MYC and ADA (Figure 8c ), consistent with a role for FLASH as a transcriptional co-regulator of c-Myb. It is noteworthy that the co-activation observed with FLASH is comparable with that of an established coactivator of c-Myb, p300 (Figure 7 ). Whether these two factors cooperate or activate at independent times or on different sets of c-Myb target genes remains to be investigated. But it is worth mentioning that they physically bind to non-overlapping Myb domains. While FLASH interacts with the DNA-binding domain of c-Myb, p300 interacts with the transactivation domain (Kasper et al., 2002; Zor et al., 2004; De Guzman et al., 2006) .
The mechanism for how FLASH activates c-Myb is not known, but there are several possibilities. One obvious hypothesis is classical co-activator recruitment. Concerning recruitment, it may be useful to distinguish recruitment in subnuclear foci from recruitments to promoter regions in activated genes. Confocal immunostaining addressing the first aspect shows that FLASH under most conditions is localized in very distinct foci, while c-Myb is found partially as diffuse nucleoplasmic staining and partially in foci. Overexpression of FLASH and c-Myb causes the latter to associate with FLASH mainly in distinct foci, suggesting that FLASH recruits c-Myb to its location. Reporter activation and ChIP studies addressing promoter recruitment show that FLASH makes c-Myb more efficient in activating its target genes and they are both found located in regulatory regions, suggesting recruitment in the form of a classical co-activator model where c-Myb recruits FLASH to active promoters. Consistent with this hypothesis is the reporter activation seen when FLASH in a Gal4-tethering experiment was recruited to an artificial promoter (Figure 9 ). There is not necessarily a conflict between these two models. In fact, our observations that when FLASH and c-Myb are overexpressed, both proteins co-localize with active RNA pol II foci (Figure 10b ), suggest that these subnuclear foci are sites of active transcription where all three proteins operate together to enhance gene activation. Therefore, these foci combine the localization aspect and the gene activation aspect of the recruitment issue. The upcoming research pointing to the existence of distinct transcription factories into which genes can migrate (Fraser and Bickmore, 2007; Sexton et al., 2007) may provide models of particular relevance for future FLASH research.
The role of FLASH has been enigmatic since its discovery in 1999, but a more consistent picture is now emerging where FLASH clearly operates in the nucleus was measured by quantitative real-time PCR with primers specific for mim-1 and HPRT as described in Materials and Methods. The mim-1 expressions are presented as fractions relative to the HPRT expression±s.e.m. (b) K562 cells were transfected with siRNAs directed against FLASH as described in Materials and Methods. Cell pellets from 1.5 Â 10 5 K562 cells from each siRNA transfection were boiled in SDS loading buffer, sonicated and subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western immunoblotting with rabbit anti-FLASH, mouse anti-c-Myb (5e11) and mouse anti-tubulin as indicated. (c) Effects of FLASH knockdown on the endogenous Myb target genes MYC and ADA were measured by quantitative real-time PCR using specific primers for the target genes and the POLR2A reference gene. The results are presented as MYC or ADA expression (normalized for POLR2A expression) after FLASH knock-down relative to their expressions in the knock-down control and presented as mean±s.e.m. of independent biological assays, each analysed in triplicate. Statistical significance was calculated using the Student's t-test (P-value indicated). (d) Chromatin immunoprecipitations (ChIP) with K562 cells were performed to assess occupancy of both c-Myb and FLASH on the MYC promoter and the ADA enhancer. For FLASH we also included the H3 promoter as a positive control for FLASH occupancy (Barcaroli et al., 2006a) . Results are expressed as fold enrichment relative to the IgG control antibody. Error bars (s.e.m.) were calculated from two sets of three independent real-time PCR reactions from two different immunoprecipitations, and results are representative of multiple ChIP experiments.
FLASH: co-activator of c-Myb AH Alm-Kristiansen et al affecting specific transcriptional processes. Three systems are now reported to be influenced by FLASH: c-Myb-dependent transcription (this work), MR-and GR-mediated transcription (Kino and Chrousos, 2003; Kino et al., 2004; Obradovic et al., 2004) and the activation of histone gene transcription (Barcaroli et al., 2006a) . Therefore, FLASH may well act as a coactivator for a range of transcription factors. Consistent with this hypothesis, we observed positive ChIP-signals for FLASH also on two genes that are not c-Myb responsive (results not shown). The high frequency of association between FLASH and RNA polymerase II Figure 10 FLICE-associated huge protein (FLASH) and c-Myb co-localizes with active RNA polymerase II. CV-1 cells were analysed by indirect immunofluorescence and confocal microscopy. (a) Endogenous (upper panels) and transfected FLASH (lower panels) were detected with rabbit anti-FLASH antibody and Alexa Fluor 488 goat anti-rabbit IgG (green signal). RNA polymerase II phosphorylated on Ser-5 in the CTD was detected with a mouse monoclonal anti-pol II (8A7) IgM antibody and Alexa Fluor 546 goat anti-mouse IgM, specific for the IgM heavy chains (orange signal). (b) CV-1 cells were transfected with plasmids encoding HA-FLASH and c-Myb-FLAG. FLASH and active RNA polymerase II were detected as described in a. c-Myb was detected with mouse anti-FLAG antibody and Alexa Fluor 633 goat anti-mouse IgG1, specific for the IgG1 heavy chains (blue signal). Merged images are visualized in right panel.
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AH Alm-Kristiansen et al foci, as shown in this work, may be a clue to a better understanding of FLASH function. Our working hypothesis is that FLASH might bridge several transcription factors and the polymerase. Further experiments are certainly needed to elucidate in full detail the mechanism of how FLASH cooperates with RNA polymerase II and activates c-Myb, as well as its role in other transcription systems.
Materials and methods
Yeast two-hybrid screening
The yeast two-hybrid screening with c-Myb full-length as bait was performed as described (Dahle et al., 2003) and validated as outlined in Supplementary Information.
Cells, transfections, immunofluorescence and confocal laser scanning microscopy Cells were cultured and transfected using standard methods. Fixation and processing of cells for immunofluorescence analysis were performed as detailed in Supplementary Information.
Preparation of cell lysates and nuclear extracts for use in immunoblotting and immunoprecipitation Cytoplasmic and nuclear extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce Biotechnology, Inc., Rockford, IL, USA), the Nuclear Complex Co-IP kit (Active Motif, Carlsbad, CA, USA) or the CelLytic NuCLEAR Extraction Kit (Sigma-Aldrich, St Louis, MO, USA). Immunoprecipitations and immunoblotting were performed as outlined in Supplementary Information.
Reporter gene assays
Reporter gene assays in transfected CV-1 cells were performed as previously described and outlined in Supplementary Information.
RNA interference, RNA isolation and quantitative real-time PCR RNA interference was performed as previously described . RNA was extracted using Absolutely RNA RT-PCR Miniprep kit (Stratagene, La Jolla, CA, USA) (HD11 cells) or TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA, USA) followed by purification with RNeasy (Qiagen, Valencia, CA, USA) (K562 cells). Quantitative realtime PCR cDNA was performed as described in Supplementary Information.
Chromatin Immunoprecipitation K562 cells were crosslinked and processed according to standard methods using quantitative real-time PCR for quantification. See Supplementary Information.
